The third annual joint influenza surveillance meeting was held in Istanbul. The meeting focused on virological and epidemiological aspects of influenza surveillance, influenza vaccination, and new developments in the field of influenza prevention and control.
In accordance with the Key Tasks, ERLI-Net laboratories should participate in external quality assurance (EQA) schemes. EQA panels are distributed by both ERLI-Net and the WHO.
The levels of influenza activity in European countries reported by EISN members during the influenza season are based on three assessments: An indicator of the overall intensity of influenza activity in the country, An indicator of the geographical spread of influenza in the country, An indicator of trend in ILI/ARI sentinel consultations in the country compared to the previous week.
The human immunodeficiency virus (HIV) remains one of the most important communicable diseases in Europe. It is an infection associated with serious disease, persistently high costs of treatment and care, significant number of deaths and shortened life expectancy.
Since 2008, ECDC and the WHO Regional Office for Europe co-ordinate enhanced HIV/AIDS surveillance in Europe covering all 53 countries in the WHO European Region.